title: A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia.
abstract: BACKGROUND
  BALB/c mice and C57/BL6 mice have different abilities to recover from ischemia. C57/BL6 mice display increased vessel collateralization and vascular endothelial growth factor expression with a consequent rapid recovery from ischemia compared with BALB/c mice. Mesenchymal stem cells (MSCs) are one of the main cell types that contribute to the recovery from ischemia because, among their biological activities, they produce several proangiogenic paracrine factors and differentiate into endothelial cells. The objective of this study was to evaluate whether the MSCs of these two mouse strains have different inductive capacities for recovering ischemic limbs.
  
  
  METHODS
  MSCs from these two strains were obtained from the bone marrow, purified and characterized before being used for in vivo experiments. Limb ischemia was surgically induced in BALB/c mice, and MSCs were injected on the fifth day. The evolution of limb necrosis was evaluated over the subsequent month. Muscle strength was assessed on the 30th day after the injection, and then the animals were sacrificed to determine the muscle mass and perform histological analyses to detect cellular infiltration, capillary and microvessel densities, fibrosis, necrosis and tissue regeneration.
  
  
  RESULTS
  The MSCs from both strains promoted high level of angiogenesis similarly, resulting in good recovery from ischemia. However, BALB/c MSCs promoted more muscle regeneration (57%) than C57/BL6 MSCs (44%), which was reflected in the increased muscle strength (0.79 N versus 0.45 N).
  
  
  CONCLUSIONS
  The different genetic background of MSCs from BALB/c mice and C57/BL6 mice was not a relevant factor in promoting angiogenesis of limb ischemia, because both cells showed a similar angiogenic activity. These cells also showed a potential myogenic effect, but the stronger effect promoted by BALB/c MSCs indicates that the different genetic background of MSCs was more relevant in myogenesis than angiogenesis.
authors.forename: Flavia Franco
authors.initials: FF
authors.lastname: Cunha
authors.forename: Leonardo
authors.initials: L
authors.lastname: Martins
authors.forename: Priscila Keiko Matsumoto
authors.initials: PK
authors.lastname: Martin
authors.forename: Roberta Sessa
authors.initials: RS
authors.lastname: Stilhano
authors.forename: Sang Won
authors.initials: SW
authors.lastname: Han
mesh_terms: D000818:Animals; D001853:Bone Marrow; D064987:Cell- and Tissue-Based Therapy; D004195:Disease Models, Animal; D042783:Endothelial Cells / Q000378:metabolism*; D006614:Hindlimb / Q000098:blood supply* / Q000473:pathology; D007511:Ischemia / Q000378:metabolism* / Q000473:pathology; D008297:Male; D059630:Mesenchymal Stem Cells; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018919:Neovascularization, Physiologic
references.citation: Stem Cells. 2004;22(3):377-84
references.pmid: 15153614
references.citation: Stem Cells. 2006 Jun;24(6):1620-6
references.pmid: 16497946
references.citation: Science. 2005 Jul 8;309(5732):314-7
references.pmid: 16002622
references.citation: Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2196-203
references.pmid: 16473959
references.citation: Cell Physiol Biochem. 2007;20(6):867-76
references.pmid: 17982269
references.citation: J Gene Med. 2009 Apr;11(4):345-53
references.pmid: 19194978
references.citation: Gene Ther. 2003 Apr;10(8):621-9
references.pmid: 12692590
references.citation: J Cell Mol Med. 2010 Sep;14(9):2190-9
references.pmid: 20716123
references.citation: Circulation. 2004 Mar 30;109(12):1543-9
references.pmid: 15023891
references.citation: Pediatr Transplant. 2007 Nov;11(7):814-7
references.pmid: 17910665
references.citation: Stem Cells Dev. 2010 Oct;19(10):1511-22
references.pmid: 20170363
references.citation: Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):520-6
references.pmid: 16397137
references.citation: Cell Stem Cell. 2008 Feb 7;2(2):141-50
references.pmid: 18371435
references.citation: Clin J Am Soc Nephrol. 2011 Feb;6(2):412-22
references.pmid: 20930086
references.citation: Stem Cells. 2009 Jan;27(1):238-49
references.pmid: 18772314
references.citation: Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75
references.pmid: 17140820
references.citation: Mol Biol Rep. 2012 Jan;39(1):285-93
references.pmid: 21553056
references.citation: Circulation. 2002 Jan 1;105(1):93-8
references.pmid: 11772882
references.citation: Clin Res Cardiol. 2007 Dec;96(12):891-9
references.pmid: 17694378
references.citation: Ann Rheum Dis. 2011 Nov;70(11):2011-21
references.pmid: 21821866
references.citation: Blood. 2007 Nov 15;110(10):3499-506
references.pmid: 17664353
references.citation: J Biomech. 2010 Apr 19;43(6):1176-81
references.pmid: 20022602
references.citation: Exp Hematol. 2004 Dec;32(12):1238-45
references.pmid: 15588948
references.citation: Circulation. 2004 Sep 14;110(11 Suppl 1):II213-8
references.pmid: 15364865
references.citation: Intern Emerg Med. 2011 Oct;6 Suppl 1:129-34
references.pmid: 22009625
references.citation: PLoS One. 2012;7(3):e33944
references.pmid: 22470498
references.citation: Circulation. 2005 Jan 18;111(2):150-6
references.pmid: 15642764
references.citation: J Clin Invest. 2004 Feb;113(4):516-27
references.pmid: 14966561
references.citation: Circulation. 2005 Jul 26;112(4):521-6
references.pmid: 16027258
references.citation: Physiol Genomics. 2007 Jul 18;30(2):179-91
references.pmid: 17426116
references.citation: Circulation. 2003 Jan 28;107(3):461-8
references.pmid: 12551872
references.citation: Blood. 2007 Jan 1;109(1):228-34
references.pmid: 16985180
references.citation: Circulation. 2004 Mar 16;109(10):1215-8
references.pmid: 15007007
references.citation: Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2308-14
references.pmid: 18849336
references.citation: Lancet. 2008 May 10;371(9624):1579-86
references.pmid: 18468541
references.citation: Cardiovasc Res. 2005 Jun 1;66(3):543-51
references.pmid: 15914119
references.citation: Cell Physiol Biochem. 2006;17(5-6):279-90
references.pmid: 16791003
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3422-7
references.pmid: 10725398
references.citation: Arthritis Rheum. 2005 Aug;52(8):2521-9
references.pmid: 16052568
references.citation: Tokai J Exp Clin Med. 2006 Sep 20;31(3):128-32
references.pmid: 21302240
references.citation: Stem Cells. 2006 Jan;24(1):186-98
references.pmid: 16100003
references.citation: Stem Cells. 2003;21(3):337-47
references.pmid: 12743328
references.citation: Blood. 2004 Mar 1;103(5):1662-8
references.pmid: 14592819
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8407-11
references.pmid: 12815096
references.citation: Science. 1999 Apr 2;284(5411):143-7
references.pmid: 10102814
references.citation: Cell Transplant. 2009;18(3):371-80
references.pmid: 19500466
references.citation: Mol Ther. 2012 Jan;20(1):14-20
references.pmid: 22008910
references.citation: Ann Thorac Surg. 2003 Jan;75(1):204-9
references.pmid: 12537217
references.citation: Stem Cells Dev. 2012 Jul 1;21(10):1761-8
references.pmid: 21970410
references.citation: Stem Cell Res Ther. 2010 Mar 15;1(1):2
references.pmid: 20504283
references.citation: Angiogenesis. 2001;4(4):247-57
references.pmid: 12197469
references.citation: Exp Cell Res. 2005 Jul 1;307(1):174-82
references.pmid: 15922737
references.citation: Circulation. 2008 Mar 4;117(9):1207-15
references.pmid: 18285563
references.citation: FASEB J. 2006 Dec;20(14):2657-9
references.pmid: 17095533
references.citation: Circ Res. 2002 May 17;90(9):966-73
references.pmid: 12016262
references.citation: Lancet. 2002 Aug 10;360(9331):427-35
references.pmid: 12241713
references.citation: Br J Haematol. 2003 Nov;123(4):702-11
references.pmid: 14616976
references.citation: J Cell Sci. 2006 Jun 1;119(Pt 11):2204-13
references.pmid: 16684817
references.citation: J Cell Biochem. 2006 Aug 1;98(5):1076-84
references.pmid: 16619257